Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (2), 335-340
- https://doi.org/10.1093/ndt/16.2.335
Abstract
Oxidative stress has long been demonstrated in haemodialysis patients. However, the factors influencing their oxidative status have not been characterized extensively in these patients. Therefore, the present study was designed to investigate the influence of a large number of factors known to be associated with oxidative stress. In the present cross-sectional study, we determined the plasma levels of lipid and protein oxidation markers in 31 non-smoking haemodialysis patients and 18 non-smoking healthy subjects, together with various components of the antioxidant system at the plasma and erythrocyte level. No influence of age, diabetes or iron overload on oxidative markers and plasma and erythrocyte antioxidant systems was detected in these haemodialysis patients. The lack of an association between iron overload and oxidative status may be related to the lower level of plasma ascorbate in haemodialysis patients, since ascorbate favours the generation of free iron from ferritin-bound iron. Interestingly, plasma C reactive protein (CRP) levels measured by highly sensitive CRP assay were correlated positively with plasma levels of thiobarbituric acid reactive substances (r=0.38, P<0.04) and negatively with plasma alpha-tocopherol levels (r=-0.46, P<0.01). Moreover, significant inverse correlations were observed between duration of dialysis treatment and plasma levels of alpha-tocopherol (r=-0.49, P<0.02) and ubiquinol (r=-0.40, P<0.05). Our results suggest that inflammatory status and duration of dialysis treatment are the most important factors relating to oxidative stress in haemodialysis patients.Keywords
This publication has 26 references indexed in Scilit:
- Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patientsKidney International, 1999
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Susceptibility of VLDL to oxidation in patients on regular haemodialysisAtherosclerosis, 1997
- Ascorbate promotes low density lipoprotein oxidation in the presence of ferritinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Evaluation of Red Blood Cell Lipoperoxidation in Hemodialysed Patients during Erythropoietin Therapy Supplemented or Not with IronNephron, 1995
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994
- Serum Coenzyme Q10 in Uremic Patients on Chronic HemodialysisNephron, 1994
- Establishing the Relationship between Complement Activation and Stimulation of Phagocyte Oxidative Metabolism in Hemodialyzed Patients: A Randomized Prospective StudyNephron, 1991
- Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodKidney International, 1985